ArticleActa Cardiologica Sinica2023

Long-Term Experience and Safety of Transitioning from Subcutaneous Treprostinil to Oral Selexipag in the High-Risk Pulmonary Hypertension Patient: A Case Report.

Yung-Hsiang Ting et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.